TY - JOUR
T1 - Very Late Recurrence of Hepatocellular Carcinoma After Liver Transplantation
T2 - Case Report and Literature Review
AU - Schreibman, Ian
AU - Bejarano, P.
AU - Martinez, E. J.
AU - Regev, A.
PY - 2006/11
Y1 - 2006/11
N2 - Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.
AB - Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.
UR - http://www.scopus.com/inward/record.url?scp=33750965911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750965911&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2006.08.095
DO - 10.1016/j.transproceed.2006.08.095
M3 - Article
C2 - 17112921
AN - SCOPUS:33750965911
SN - 0041-1345
VL - 38
SP - 3140
EP - 3143
JO - Transplantation proceedings
JF - Transplantation proceedings
IS - 9
ER -
